Parvovirus B19 in stem cell transplantation
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14138 ↗Kurz gefasst
Editorial in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Paul M Kinsella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Hematopoietic Stem Cell Transplantation, Erythema Infectiosum, Parvoviridae Infections. Die Arbeit nennt 11 Literaturangaben. Gefördert von: National Health and Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
- Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Victoria, Australia.
ORCID-Profile: Michelle K Yong, Monica A Slavin, Victoria G Hall
Förderung
- National Health and Medical Research
Zitieren
APA
Kinsella, P. M., Yong, M. K., Slavin, M. A., & Hall, V. G. (2023). Parvovirus B19 in stem cell transplantation. Transplant Infectious Disease. https://doi.org/10.1111/tid.14138
Vancouver
Kinsella PM, Yong MK, Slavin MA, Hall VG. Parvovirus B19 in stem cell transplantation. Transplant Infectious Disease. 2023. doi:10.1111/tid.14138
BibTeX
@article{Kinsella2023,
author = {Kinsella, Paul M and Yong, Michelle K and Slavin, Monica A and Hall, Victoria G},
title = {Parvovirus B19 in stem cell transplantation},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14138}
}
EUVIMED